Rohto's expansion in RI

Rohto's expansion in RI

TOKYO (Reuter): Rohto Pharmaceutical Co Ltd said on Wednesday
that it would expand its business in Indonesia and China.

In Indonesia, Rohto will set up PT Rohto Laboratories
Indonesia with the Gemala Group of Indonesia, Rohto said in a
statement.

The venture, capitalized at about 200 million yen, will be
owned 60 percent by Rohto and 40 percent by Gemala. It will be
headquartered in Jakarta but a plant will be set up about 170 km
southeast of the Indonesian capital, it said.

The venture will replace production and sales of eye drops by
an Indonesian state-owned company, Rohto said. The state firm has
been making and selling eye drops under a license pact with
Rohto.

The venture will also make and sell lenses for use in
operations for cataract patients.

Sales of eye drops, to start by the end of this year, are
expected to total 200 million yen in the initial year, Rohto
said. Sales of lenses, also to begin by the end of this year, are
also expected at 200 million yen in the initial year.